loading...
Distributed by Mapi Research Trust
Distributed by Mapi Research Trust
Developed in 1990 and revised in 1997
A version for Adolescent has been created in 2015: ESS-CHAD
WEBINAR: An Author Webinar on the Epworth Sleepiness Scale - Recorded session available here!
Johns MW
Sleepiness
Johns MW. The clinical assessment of daytime sleepiness in patients with obstructive sleep apnea. In:Surgery for snoring and obstructive sleep apnea syndrome, ed. Fabiani M. Kugler publications, The Hague, 2003: 283-295
Johns MW. Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the epworth sleepiness scale: failure of the MSLT as a gold standard. J Sleep Res. 2000 Mar;9(1):5-11 (PubMed abstract)
Johns MW. Sleepiness in different situations measured by the Epworth Sleepiness Scale. Sleep. 1994 Dec;17(8):703-10 (PubMed abstract)
Johns MW. Daytime sleepiness, snoring, and obstructive sleep apnea. The Epworth Sleepiness Scale. Chest. 1993 Jan;103(1):30-6 (PubMed abstract)
Johns MW. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep. 1992 Aug;15(4):376-81 (PubMed abstract)
Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991 Dec;14(6):540-5 (PubMed abstract)
Johns MW
Dr Murray W Johns
P.O. Box 232
Flinders, VIC 3121,
Australia
E-mail: mjohns@optalert.com
Murray W Johns Publications (PubMed)
Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66
You may access the questionnaire and/or its available translations directly (see tutorial). Should you not see the Download button, please contact us.
Fees may apply to your project. Submit your request (see tutorial). Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner.
Additional information on the ESS website
Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.
The list of available translations is subject to constant changes and may not be exhaustive. It is provided for information only. Some recently produced translations may not be included in the list below yet. Please do check the status of available translations with Mapi Research Trust / the developers / copyright holders / distributors.
Also, the listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study.
The author has selected Mapi/ICON Language Services as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.
For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).
If you wish to translate the questionnaire:
A license agreement must be completed and a user fee is required by all users (commercial & academic users) and a screenshot review agreement must be signed by commercial users. Please submit a request.
The work performed can be certified once it has been confirmed as being in line with the instructions of the ESS e-Booklet.
Screenshots review of the original version:
Usability testing of the original version performed by Experts:
If applicable for a specific scope and budget, after implementation of the ESS into the device(s), the User and/or eCOA Company will provide Mapi/ICON with a test device or the on-line connection, in order to assess the overall usability of the solution, with the target patient population(s) in mind including clarity, navigation, font size, and device usability.
Screenshots review of target language:
The Questionnaire e-Booklet, developed in collaboration with the Owner, is intended to accompany the User through the development of official, validated, and approved electronic versions of the Questionnaire. It includes instructions and checklists on instrument properties and configuration, content, navigation, workflow diagram, format and provides a model about how the electronic version of the Questionnaire must be displayed (i.e. the “Original electronic Versions” (“OeVs”) of the Questionnaire).
e-Booklet Status:
e-Booklet Current Version: ESS_AU1.0_e-Booklet_2.0
Compatible Devices:
Please do make sure to consider the target population when selecting a device for a specific study.
(1)for password protected clinical trial projects only.
(2)Web versions should only be authorized for screens of 1024px or larger, i.e. mobile device cannot access the Web versions or a disclaimer should be stated otherwise. Upon termination of the User Agreement between the User and MRT, the User shall immediately cease the use of the e-PRO and shall destroy any material related to the e-PRO in the system by erasing them from the magnetic mediate on which they are stored and certify in writing that they have been destroyed.
(3)The User acknowledges that devices, non-compliant with the approved modalities specification as detailed above, will not be certified. The User shall be responsible for any consequences arising out from the use by the patients of any non-approved devices and in particular non-approved screen sizes.
The information below is related to the versions certified by MRT on behalf of the copyright holder/author.
Vendor Name |
Original e-Version Language |
e-Booklet Version |
Type of Device |
Category of Device |
Name of Device |
IQVIA |
English for the USA |
ESS_AU1.0_e-Booklet_2.1 |
Handheld |
Mobile ios |
iPhone 6 |
IQVIA |
English for the USA |
ESS_AU1.0_e-Booklet_2.1 |
Tablet |
Tablet ios |
iPad Air 2 |
Inspire Sleep |
English for the USA |
ESS_AU1.0_e-Booklet_2.0 |
BYOD |
Mobile ios |
|
For any other validated devices, please submit a request.
Access to advanced descriptions of Clinical Outcome Assessments (COAs)